Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening
- PMID: 17951261
- DOI: 10.1074/jbc.M703988200
Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening
Abstract
The propagation of the hepatitis C virus (HCV) is a complex process that requires both host and viral proteins. To facilitate identification of host cell factors that are required for HCV replication, we screened a panel of small interference RNAs that preferentially target human protein kinases using an HCV replicon expressing the firefly luciferase gene as a genetic reporter. Small interference RNAs specific for three human kinases, Csk, Jak1, and Vrk1, were identified that reproducibly reduce viral RNA and viral protein levels in HCV replicon-bearing cells. Treatment of replicon cells with a small molecule inhibitor of Csk also resulted in a significant reduction in HCV RNA and proteins, further supporting a role for Csk in HCV replication. The effects of siRNAs targeting eight kinases known to be negatively regulated by Csk were then examined; knock down of one of these kinases, Fyn, resulted in up-regulation of the HCV replicon, suggesting that Csk mediates its effect on HCV replication through Fyn. This conclusion was further corroborated by demonstration that replicon cells treated with Csk inhibitor contained lower levels of the phosphorylated form of Fyn than control cells.
Similar articles
-
Potential for Protein Kinase Pharmacological Regulation in Flaviviridae Infections.Int J Mol Sci. 2020 Dec 15;21(24):9524. doi: 10.3390/ijms21249524. Int J Mol Sci. 2020. PMID: 33333737 Free PMC article. Review.
-
Identification and characterization of the role of c-terminal Src kinase in dengue virus replication.Sci Rep. 2016 Jul 26;6:30490. doi: 10.1038/srep30490. Sci Rep. 2016. PMID: 27457684 Free PMC article.
-
Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.J Virol. 2011 Dec;85(23):12292-303. doi: 10.1128/JVI.05920-11. Epub 2011 Sep 21. J Virol. 2011. PMID: 21937640 Free PMC article.
-
Polo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A.J Virol. 2010 Aug;84(16):7983-93. doi: 10.1128/JVI.00068-10. Epub 2010 Jun 9. J Virol. 2010. PMID: 20534861 Free PMC article.
-
[Replication of hepatitis C virus genome].Uirusu. 2008 Dec;58(2):191-8. Uirusu. 2008. PMID: 19374197 Review. Japanese.
Cited by
-
The Envelope (E) Protein of SARS-CoV-2 as a Pharmacological Target.Viruses. 2023 Apr 19;15(4):1000. doi: 10.3390/v15041000. Viruses. 2023. PMID: 37112980 Free PMC article. Review.
-
Cytoplasmic delivery of siRNA using human-derived membrane penetration-enhancing peptide.J Nanobiotechnology. 2022 Oct 27;20(1):458. doi: 10.1186/s12951-022-01667-4. J Nanobiotechnology. 2022. PMID: 36303212 Free PMC article.
-
Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication.Cell Rep. 2021 Apr 6;35(1):108940. doi: 10.1016/j.celrep.2021.108940. Epub 2021 Mar 18. Cell Rep. 2021. PMID: 33784499 Free PMC article.
-
Targeting Crucial Host Factors of SARS-CoV-2.ACS Infect Dis. 2020 Nov 13;6(11):2844-2865. doi: 10.1021/acsinfecdis.0c00456. Epub 2020 Oct 28. ACS Infect Dis. 2020. PMID: 33112126 Free PMC article. Review.
-
Repurposing of Kinase Inhibitors for Treatment of COVID-19.Pharm Res. 2020 Aug 10;37(9):167. doi: 10.1007/s11095-020-02851-7. Pharm Res. 2020. PMID: 32778962 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous